106 related articles for article (PubMed ID: 38310574)
21. MicroRNA-6077 enhances the sensitivity of patients-derived lung adenocarcinoma cells to anlotinib by repressing the activation of glucose transporter 1 pathway.
Ma DB; Qin MM; Shi L; Ding XM
Cell Signal; 2019 Dec; 64():109391. PubMed ID: 31421224
[TBL] [Abstract][Full Text] [Related]
22. ELF1 suppresses autophagy to reduce cisplatin resistance via the miR-152-3p/NCAM1/ERK axis in lung cancer cells.
Zhao L; Wu X; Zhang Z; Fang L; Yang B; Li Y
Cancer Sci; 2023 Jun; 114(6):2650-2663. PubMed ID: 36846943
[TBL] [Abstract][Full Text] [Related]
23. Circ_0020123 enhances the cisplatin resistance in non-small cell lung cancer cells partly by sponging miR-140-3p to regulate homeobox B5 (HOXB5).
Wei D; Zeng J; Rong F; Xu Y; Wei R; Zou C
Bioengineered; 2022 Mar; 13(3):5126-5140. PubMed ID: 35170372
[TBL] [Abstract][Full Text] [Related]
24. LncRNA SNHG12 contributes to multidrug resistance through activating the MAPK/Slug pathway by sponging miR-181a in non-small cell lung cancer.
Wang P; Chen D; Ma H; Li Y
Oncotarget; 2017 Oct; 8(48):84086-84101. PubMed ID: 29137407
[TBL] [Abstract][Full Text] [Related]
25. Circ_0011292 knockdown mitigates progression and drug resistance in PTX-resistant non-small-cell lung cancer cells by regulating miR-433-3p/CHEK1 axis.
Jin M; Zhang F; Li Q; Xu R; Liu Y; Zhang Y
Thorac Cancer; 2022 May; 13(9):1276-1288. PubMed ID: 35348291
[TBL] [Abstract][Full Text] [Related]
26. Retracted Article: CircRNA PVT1 modulates cell metastasis
Yan L; Bai M; Xu J; Li X; Wu C; Zhou Y; Yan J; Zhang Z
RSC Adv; 2019 Dec; 9(72):42324-42334. PubMed ID: 35542851
[TBL] [Abstract][Full Text] [Related]
27. Anlotinib Combined with S-1 in Third- or Later-Line Stage IV Non-Small Cell Lung Cancer Treatment: A Phase II Clinical Trial.
Xiang M; Yang X; Ren S; Du H; Geng L; Yuan L; Wen Y; Lin B; Li J; Zhang Y; Feng G; Du X
Oncologist; 2021 Dec; 26(12):e2130-e2135. PubMed ID: 34423518
[TBL] [Abstract][Full Text] [Related]
28. LncRNA ASAP1-IT1 enhances cancer cell stemness via regulating miR-509-3p/YAP1 axis in NSCLC.
Liu Y; Yang Y; Zhang L; Lin J; Li B; Yang M; Li H; Chen K; Zhao W
Cancer Cell Int; 2021 Oct; 21(1):572. PubMed ID: 34715859
[TBL] [Abstract][Full Text] [Related]
29. The HNF1A-AS1/miR-92a-3p axis affects the radiosensitivity of non-small cell lung cancer by competitively regulating the JNK pathway.
Wang Z; Liu L; Du Y; Mi Y; Wang L
Cell Biol Toxicol; 2021 Oct; 37(5):715-729. PubMed ID: 33755848
[TBL] [Abstract][Full Text] [Related]
30. Propofol decreases cisplatin resistance of non-small cell lung cancer by inducing GPX4-mediated ferroptosis through the miR-744-5p/miR-615-3p axis.
Han B; Liu Y; Zhang Q; Liang L
J Proteomics; 2023 Mar; 274():104777. PubMed ID: 36427803
[TBL] [Abstract][Full Text] [Related]
31. β-elemene suppresses Warburg effect in NCI-H1650 non-small-cell lung cancer cells by regulating the miR-301a-3p/AMPKα axis.
Li L; Zhao D; Cheng G; Li Q; Chu Y; Chu H; Ding Y; Li C
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32463461
[TBL] [Abstract][Full Text] [Related]
32. miR-29a-3p inhibits the malignant characteristics of non-small cell lung cancer cells by reducing the activity of the Wnt/β-catenin signaling pathway.
Zhang K; Han X; Hu W; Su C; He B
Oncol Lett; 2022 Oct; 24(4):379. PubMed ID: 36238844
[TBL] [Abstract][Full Text] [Related]
33. Circular RNA hsa_circ_0011298 enhances Taxol resistance of non-small cell lung cancer by regulating miR-486-3p/CRABP2 axis.
Wu Y; Xie J; Wang H; Hou S; Feng J
J Clin Lab Anal; 2022 May; 36(5):e24408. PubMed ID: 35396749
[TBL] [Abstract][Full Text] [Related]
34. Circular RNA circ_0002360 regulates the Taxol resistance and malignant behaviors of Taxol-resistant non-small cell lung cancer cells by microRNA-585-3p-dependent modulation of G protein regulated inducer of neurite outgrowth 1.
Cui X; Zhang B; Li B; Li X
Bioengineered; 2022 Apr; 13(4):9070-9085. PubMed ID: 35293280
[TBL] [Abstract][Full Text] [Related]
35. MiR-519d-3p enhances the sensitivity of non-small-cell lung cancer to tyrosine kinase inhibitors.
Zhen Q; Zhang Y; Gao L; Wang R; Chu W; Zhao X; Li Z; Li H; Zhang B; Lv B; Liu J
Mamm Genome; 2021 Dec; 32(6):508-516. PubMed ID: 34586488
[TBL] [Abstract][Full Text] [Related]
36. Increased PD-L1 Expression in Acquired Cisplatin-Resistant Lung Cancer Cells via Mir-181a.
Chen Y; Song W; Gao Y; Dong X; Ji X
Tohoku J Exp Med; 2022 May; 257(1):33-43. PubMed ID: 35354691
[TBL] [Abstract][Full Text] [Related]
37. Blocking circ_0014130 suppressed drug resistance and malignant behaviors of docetaxel resistance-acquired NSCLC cells via regulating miR-545-3p-YAP1 axis.
Du D; Cao X; Duan X; Zhang X
Cytotechnology; 2021 Aug; 73(4):571-584. PubMed ID: 34349347
[TBL] [Abstract][Full Text] [Related]
38. Circ_CSPP1 Regulates the Development of Non-small Cell Lung Cancer via the miR-486-3p/BRD9 Axis.
Xie D; Zhang S; Jiang X; Huang W; He Y; Li Y; Chen S; Xiong H
Biochem Genet; 2023 Feb; 61(1):1-20. PubMed ID: 35678942
[TBL] [Abstract][Full Text] [Related]
39. LncRNA NEAT1 induces autophagy through the miR-128-3p/ADAM28 axis to suppress apoptosis of nonsmall-cell lung cancer.
Xie Y; Zheng ZW; He HT; Chang ZB
Kaohsiung J Med Sci; 2022 Oct; 38(10):933-949. PubMed ID: 36054559
[TBL] [Abstract][Full Text] [Related]
40. Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway.
Tian W; Yang X; Yang H; Lv M; Sun X; Zhou B
Cell Death Dis; 2021 Oct; 12(11):1030. PubMed ID: 34718336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
